AbbVie
ABBV
#26
Rank
ยฃ299.70 B
Marketcap
ยฃ169.58
Share price
-1.15%
Change (1 day)
26.09%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): ยฃ1.14 Billion

According to AbbVie's latest financial reports the company's current earnings are ยฃ59.64 Billion. In 2024 the company made an earning of ยฃ2.78 Billion a decrease over its 2023 earnings that were of ยฃ4.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) ยฃ1.14 B-59.09%
2024 ยฃ2.78 B-40.54%
2023 ยฃ4.68 B-53.62%
2022 ยฃ10.10 B3.76%
2021 ยฃ9.74 B282.25%
2020 ยฃ2.54 B-59.67%
2019 ยฃ6.32 B62.13%
2018 ยฃ3.89 B-32.74%
2017 ยฃ5.79 B-1.99%
2016 ยฃ5.91 B18.65%
2015 ยฃ4.98 B180.5%
2014 ยฃ1.77 B-55.57%
2013 ยฃ3.99 B-6.86%
2012 ยฃ4.29 B56.05%
2011 ยฃ2.75 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ8.88 B 613.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.02 B 383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ16.87 B 1,255.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.18 B 396.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.41 B 495.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.42 B 14.70%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ6.99 B 461.62%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
ยฃ9.81 B 688.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ0.43 B-64.87%๐Ÿ‡บ๐Ÿ‡ธ USA